Emotional behavior in heterozygous rolling mouse Nagoya Cav2.1 channel mutant mice

Neurobiology of Aging

Volumn 32, Issue 3, 2011, Pages 486-496

  Takahashi, Eiki ^a   Niimi, Kimie ^a,b   Itakura, Chitoshi ^a  

^a RIKEN BRAIN SCIENCE INSTITUTE   (Japan)

^b Brain Science And Life Technology Research Foundation   (Japan)

Author keywords

Cav2.1 1 mutation; Elevated plus maze; Forced swimming test; Light dark exploration test; Marble burying behavioral test; Rolling mouse Nagoya; Serotonin; Tail suspension test; Tryptophan hydroxylase

Indexed keywords

MONOAMINE; SEROTONIN; TRYPTOPHAN HYDROXYLASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANXIETY; ARTICLE; BRAIN STEM; CAV2.1 ALPHA1 GENE; CONTROLLED STUDY; DEPRESSION; EMOTION; FORCED SWIMMING TEST; GENE; HETEROZYGOSITY; LIGHT DARK CYCLE; MALE; MAZE TEST; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SEROTONIN BRAIN LEVEL; SEROTONINERGIC SYSTEM; SYNAPTIC TRANSMISSION; TASK PERFORMANCE;

AGE FACTORS; ANALYSIS OF VARIANCE; ANIMALS; BEHAVIOR, ANIMAL; BRAIN STEM; CALCIUM CHANNELS, N-TYPE; DARK ADAPTATION; DARKNESS; DOPAMINE; EMOTIONS; EXPLORATORY BEHAVIOR; GENE EXPRESSION REGULATION; HETEROZYGOTE; MALE; MAZE LEARNING; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MUTATION; NOREPINEPHRINE; PHOSPHORYLATION; SEROTONIN; SWIMMING; TRYPTOPHAN HYDROXYLASE;

EID: 79952900159     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2009.03.001     Document Type: Article

References (40)

1. Alonso I., Barros J., Tuna A., Coelho J., Sequeiros J., Silveira I., Coutinho P. Phenotypes of spinocerebellar ataxia type 6 and familial hemiplegic migraine caused by a unique CACNA1A missense mutation in patients from a large family. Arch. Neurol. 2003, 60:610-614.
2. Berridge M.J., Lipp P., Bootman M.D. The versatility and universality of calcium signalling. Nat. Rev. Mol. Cell Biol. 2000, 1:11-21.
3. Catterall W.A. Structure and function of neuronal Ca2+ channels and their role in neurotransmitter release. Cell Calcium 1998, 24:307-323.
4. Catterall W.A. Interactions of presynaptic Ca2+ channels and snare proteins in neurotransmitter release. Ann. N.Y. Acad. Sci. 1999, 868:144-159.
5. Crawley J.N. Neuropharmacologic specificity of a simple animal model for the behavioral actions of benzodiazepines. Pharmacol. Biochem. Behav. 1981, 15:695-699.
6. Deisseroth K., Heist E.K., Tsien R.W. Translocation of calmodulin to the nucleus supports CREB phosphorylation in hippocampal neurons. Nature 1998, 392:198-202.
7. Fletcher C.F., Lutz C.M., O'Sullivan T.N., Shaughnessy J.D., Hawkes R., Frankel W.N., Copeland N.G., Jenkins N.A. Absence epilepsy in tottering mutant mice is associated with calcium channel defects. Cell 1996, 87:607-617.
8. Fletcher C.F., Tottene A., Lennon V.A., Wilson S.M., Dubel S.J., Paylor R., Hosford D.A., Tessarollo L., McEnery M.W., Pietrobon D., Copeland N.G., Jenkins N.A. Dystonia and cerebellar atrophy in Cacna1a null mice lacking P/Q calcium channel activity. FASEB J. 2001, 15:1288-1290.
9. Gainetdinov R.R., Wetsel W.C., Jones S.R., Levin E.D., Jaber M., Caron M.G. Role of serotonin in the paradoxical calming effect of psychostimulants on hyperactivity. Science 1999, 283:397-401.
10. Gomez C.M., Thompson R.M., Gammack J.T., Perlman S.L., Dobyns W.B., Truwit C.L., Zee D.S., Clark H.B., Anderson J.H. Spinocerebellar ataxia type 6: gaze-evoked and vertical nystagmus, Purkinje cell degeneration, and variable age of onset. Ann. Neurol. 1997, 42:933-950.
11. Harvey J., Wedley S., Findlay J.D., Sidell M.R., Pullar I.A. Omega-agatoxin IVA identifies a single calcium channel subtype which contributes to the potassium-induced release of acetylcholine, 5-hydroxytryptamine, dopamine, gamma-aminobutyric acid and glutamate from rat brain slices. Neuropharmacology 1996, 35:385-392.
12. Ichimaru Y., Egawa T., Sawa A. 5-HT1A-receptor subtype mediates the effect of fluvoxamine, a selective serotonin reuptake inhibitor, on marble-burying behavior in mice. Jpn. J. Pharmacol. 1995, 68:65-70.
13. Jun K., Piedras-Renteria E.S., Smith S.M., Wheeler D.B., Lee S.B., Lee T.G., Chin H., Adams M.E., Scheller R.H., Tsien R.W., Shin H.S. Ablation of P/Q-type Ca2+ channel currents, altered synaptic transmission and progressive ataxia in mice lacking the α1A-subunit. Proc. Natl. Acad. Sci. U.S.A. 1999, 96:15245-15250.
14. Katoh A., Jindal J.A., Raymond J.L. Motor deficits in homozygous and heterozygous p/q-type calcium channel mutants. J. Neurophysiol. 2007, 97:1280-1287.
15. Kawata Y., Okada M., Murakami T., Kamata A., Zhu G., Kaneko S. Pharmacological discrimination between effects of carbamazepine on hippocampal basal, Ca2+- and K+-evoked serotonin release. Br. J. Pharmacol. 2001, 133:557-567.
16. Kuhn D.M., Arthur R., States J.C. Phosphorylation and activation of brain tryptophan hydroxylase: identification of serine-58 as a substrate site for protein kinase A. J. Neurochem. 1997, 68:2203-2220.
17. Liu L., Zwingman T.A., Fletcher C.F. In vivo analysis of voltage-dependent calcium channels. J. Bioenerg. Biomembr. 2003, 35:671-865.
18. Lorenzon N.M., Lutz C.M., Frankel W.N., Beam K.G. Altered calcium channel currents in Purkinje cells of the neurological mutant mouse leaner. J. Neurosci. 1998, 18:4482-4489.
19. Luvisetto S., Marinelli S., Panasiti M.S., D'Amato F.R., Fletcher C.F., Pavone F., Pietrobon D. Pain sensitivity in mice lacking the Ca2, 1α1 subunit of P/Q-type Ca2+ channels. Neuroscience 2006, 142:823-832.
20. Mendoza I.E., Schmachtenberg O., Tonk E., Fuentealba J., Díaz-Raya P., Lagos V.L., García A.G., Cárdenas A.M. Depolarization-induced ERK phosphorylation depends on the cytosolic Ca2+ level rather than on the Ca2+ channel subtype of chromaffin cells. J. Neurochem. 2003, 86:1477-1486.
21. Mikami A., Imoto K., Tanabe T., Niidome T., Mori Y., Takeshima H., Narumiya S., Numa S. Primary structure and functional expression of the cardiac dihydropyridine-sensitive calcium channel. Nature 1989, 340:230-233.
22. Mori Y., WakamoriF M., Oda S., Fletcher C.F., Sekiguchi N., Mori E., Copeland N.G., Jenkins N.A., Matsushita K., Matsuyama Z., Imoto K. Reduced voltage sensitivity of activation of P/Q-type Ca2+ channels is associated with the ataxic mouse mutation rolling Nagoya (tg(rol)). J. Neurosci. 2000, 20:5654-5662.
23. Nakamura T., Honda M., Kimura S., Tanabe M., Oda S., Ono H. Taltirelin improves motor ataxia independently of monoamine levels in rolling mouse nagoya, a model of spinocerebellar atrophy. Biol. Pharm. Bull. 1992, 28:2244-2247.
24. Niimi K., Takahashi E., Itakura C. Emotional behavior and expression patterns of tyrosine hydroxylase and tryptophan hydroxylase in senescence-accelerated mouse (SAM) P6 mice. Behav. Brain Res. 2008, 188:329-336.
25. Oda S. The observation of rolling mouse Nagoya (rol), a new neurological mutant, and its maintenance. Exp. Anim. 1973, 22:281-286.
26. Pellow S., Chopin P., File S.E., Briley M. Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J. Neurosci. Methods 1995, 1985:149-167.
27. Pietrobon D. Function and dysfunction of synaptic calcium channels: insights from mouse models. Curr. Opin. Neurobiol. 2005, 15:257-265.
28. Porsolt R.D., Bertin A., Jalfre M. "Behavioural despair" in rats and mice: strain differences and the effects of imipramine. Eur. J. Pharmacol. 1978, 51:291-294.
29. Reid C.A., Bekkers J.M., Clements J.D. Presynaptic Ca2+ channels: a functional patchwork. Trends Neurosci. 2003, 26:683-687.
30. Rhyu I.J., Nahm S.S., Hwang S.J., Kim H., Suh Y.S., Oda S.I., Frank T.C., Abbott L.C. Altered neuronal nitric oxide synthase expression in the cerebellum of calcium channel mutant mice. Brain Res. 2003, 977:129-140.
31. Rodgers R.J., Nikulina E.M., Cole J.C. Dopamine D1 and D2 receptor ligands modulate the behaviour of mice in the elevated plus maze. Pharmacol. Biochem. Behav. 1994, 49:985-995.
32. Sawada K., Sakata-Haga H., Hisano S., Fukui Y. Topological relationship between corticotropin-releasing factor-immunoreactive cerebellar afferents and tyrosine hydroxylase-immunoreactive Purkinje cells in a hereditary ataxic mutant, rolling mouse Nagoya. Neuroscience 2001, 102:925-935.
33. Sawada K., Kawano M., Tsuji H., Sakata-Haga H., Hisano S., Fukui Y. Over-expression of corticotropin-releasing factor mRNA in inferior olivary neurons of rolling mouse Nagoya. Brain Res. Mol. Brain Res. 2003, 117:190-195.
34. Steru L., Chermat R., Thierry B., Simon P. The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology 1985, 85:367-370.
35. Spacey S.D., Hildebrand M.E., Materek L.A., Bird T.D., Snutch T.P. Functional implications of a novel EA2 mutation in the P/Q-type calcium channel. Ann. Neurol. 2004, 56:213-220.
36. Thomsen L.L., Kirchmann M., Bjornsson A., Stefansson H., Jensen R.M., Fasquel A.C., Petursson H., Stefansson M., Frigge M.L., Kong A., Gulcher J., Stefansson K., Olesen J. The genetic spectrum of a population-based sample of familial hemiplegic migraine. Brain 2007, 130:346-356.
37. Walther T., Voigt J.P., Fink H., Bader M. Sex specific behavioural alterations in Mas-deficient mice. Behav. Brain Res. 2000, 107:105-109.
38. Yokoyama C.T., Myers S.J., Fu J., Mockus S.M., Scheuer T., Catterall W.A. Mechanism of SNARE protein binding and regulation of Cav2 channels by phosphorylation of the synaptic protein interaction site. Mol. Cell Neurosci. 2005, 28:1-17.
39. Zhou Q.Y., Palmiter R.D. Dopamine-deficient mice are severely hypoactive, adiposic, and aphagic. Cell 1995, 83:1197-1209.
40. Zhuang X., Gross C., Santarelli L., Compan V., Trillat A.C., Hen R. Altered emotional states in knockout mice lacking 5-HT1A or 5-HT1B receptors. Neuropsychopharmacology 1999, (2, Suppl.):52S-60S.